基本信息
浏览量:28
职业迁徙
个人简介
He has extensive knowledge in molecular biology, cellular biology and in identification of potential anticancer drugs. Dr. Gartel is an academic editor of PLOS One and a reviewer for many different grant agencies, including National Institute of Health (NIH), Medical Research Council (United Kingdom) and the Welcome Trust (United Kingdom). Earlier, Dr. Gartel’s major contribution to the field was a discovery that c-Myc negatively regulates transcription of the CDK inhibitor p21 via interaction with transcription factors Sp1/Sp3. In addition, his laboratory discovered the presence of alternate p21 transcripts that are strongly regulated by p53 in human and mouse cells.
研究兴趣
论文共 140 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cell death discoveryno. 1 (2024): 211-211
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCERno. 6 (2023): 189015-189015
I. Khan, A. Kaempf,S. Raghuwanshi, M. Chesnokov, X. Zhang, Z. Wang, A. Domling,J. W. Tyner,C. Camacho,A. L. Gartel
Blood Cancer Journalno. 1 (2023): 1-5
Irum Khan, Sandjeev Raghuwanshi,Andy Kaempf, Jeff Tyner, Alex Dömling,Carlos J. Camacho,Andrei L. Gartel
Blood cancer discoveryno. 3_Supplement (2023): A09-A09
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn